Cytokine Assay for Early Identification of Pediatric Stem Cell Transplant Recipients at Risk for Respiratory Failure
N/A
N/A
21 Years
N/A
21 Years
Open (Enrolling)
Both
Stem Cell Transplantation, Blood and Marrow Transplant (BMT)
Both
Stem Cell Transplantation, Blood and Marrow Transplant (BMT)
Trial Information
Cytokine Assay for Early Identification of Pediatric Stem Cell Transplant Recipients at Risk for Respiratory Failure
Inclusion Criteria:
- Hematopoietic stem cell transplantation (HSCT) for any indication.- Patients will range from age 0 to age 21. There is no gender restriction. We expect
the male to female ratio to end up being about 50/50
- Ability to understand and the willingness to sign a written informed consent
document.
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Principal Investigator
Rajni Agarwal-Hashmi
Investigator Role:
Principal Investigator
Investigator Affiliation:
Stanford University
Authority:
United States: Institutional Review Board
Study ID:
SU-09222008-1301
NCT ID:
NCT01135355
Start Date:
July 2008
Completion Date:
July 2011
Related Keywords:
- Stem Cell Transplantation
- Blood and Marrow Transplant (BMT)
- Respiratory Insufficiency
Name | Location |
|---|---|
| Stanford University School of Medicine | Stanford, California 94305-5317 |
